Clinical Trials in Colorado

Showing 17501-17520 of 18,143 trials

Minimally Invasive Surgical Therapy for BPH

NCT00064649

The primary objective of this randomized clinical trial is to determine the efficacy and safety of three treatments for benign prostatic hyperplasia (BPH): transurethral needle ablation (TUNA), transurethral microwave therapy (TUMT), and medical therapy with alfuzosin and finasteride.

Benign Prostatic Hyperplasia

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)49 participantsStarted Apr 2004

Denver, Colorado, United States • Chicago, Illinois, United States • Rochester, Minnesota, United States +4 more locations

COMPLETEDPhase 350 miles

Rasburicase Versus Allopurinol in Tumor Patients at Risk for Hyperuricemia and Tumor Lysis Syndrome

NCT00230178

This is a randomized, multi-center, open-label, parallel group study with three arms: * Rasburicase alone * Rasburicase followed by Allopurinol * Allopurinol alone The primary objective is to compare the adequacy of control of plasma uric acid concentration and the safety profile among the three arms.

Tumor Lysis SyndromeCancerHyperuricemia

Sanofi280 participantsStarted Apr 2004

Berkeley, California, United States • Los Angeles, California, United States • Denver, Colorado, United States +12 more locations

Minimally Invasive Surgical Therapy for BPH

Rasburicase Versus Allopurinol in Tumor Patients at Risk for Hyperuricemia and Tumor Lysis Syndrome

Find Trials by Condition in Colorado

A Phase III Trial For Patients With Metastatic Breast Cancer

SGS742 in Patients With Mild to Moderate Alzheimer's Disease (AD)

Biological Effects of Dehydroepiandrosterone (DHEA) in the Elderly

The Effect of Oral D-Ribose in "Baby Boomers" With Fatigue. A Randomized, Double-Blind Study

A Phase 1-2, XIAP Antisense AEG35156 With Weekly Paclitaxel in Patients With Advanced Breast Cancer

International Immune Tolerance Study

A Study to Test the Effectiveness and Safety of a New Higher 40mg Dose of Copaxone® Compared to Copaxone® 20mg, the Currently Approved Dose

Memory Impairment Study (Mild Cognitive Impairment Study)

Efficacy, Safety, & Pharmacokinetics of Candesartan Cilexetil in Hypertensive Paediatric Subjects 6 to < 17 Years of Age

Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke

North American Study for the Treatment of Refractory Ascites (NASTRA)

Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP)

A Trial With Dronedarone to Prevent Hospitalization or Death in Patients With Atrial Fibrillation

SU011248 In The Treatment Of Patients With Bevacizumab (Avastin)-Refractory Metastatic Renal Cell Carcinoma

Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study

A Study to Evaluate the Pharmacokinetics of VI-0521 Subjects With Renal Impairment

Paclitaxel With or Without PSC 833 in Treating Patients With Metastatic Breast Cancer

Quality of Life in Pediatric Inflammatory Bowel Disease